Placental syndromes and long-term risk of hypertension

Abigail Fraser1, Janet M Catov2

  • 1Population Health Sciences, Bristol Medical School and the MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK. abigail.fraser@bristol.ac.uk.

Insights

High blood pressure before pregnancy increases risks for placental syndromes, impacting maternal cardiovascular health long-term. Further research is needed to clarify the cause-and-effect relationship for better prevention and treatment.

Area of Science:

  • Obstetrics and Gynecology
  • Cardiovascular Health
  • Reproductive Medicine

Background:

  • Elevated pre-pregnancy blood pressure is linked to adverse pregnancy outcomes like placental abruption, preeclampsia, preterm birth, and fetal growth restriction.
  • These conditions, collectively termed placental syndromes, stem from impaired placentation and early placental vascularization.
  • Placental syndromes increase maternal risk for developing hypertension and cardiovascular disease (CVD) later in life, especially when combined with placental maternal vascular malperfusion (MVM).

Purpose of the Study:

  • To review the complex relationship between maternal blood pressure and pregnancy health.
  • To explore whether placental impairment contributes to or results from elevated blood pressure during pregnancy.
  • To highlight the need for comprehensive studies to resolve the causality between blood pressure and pregnancy complications.

Main Methods:

  • This is a review article, synthesizing existing research on blood pressure, placental syndromes, and long-term maternal cardiovascular health.
  • It examines the association between pre-pregnancy hypertension, placental syndromes, and maternal vascular malperfusion.
  • The review discusses the current understanding and gaps in knowledge regarding the etiological relationship.

Main Results:

  • Higher pre-pregnancy blood pressure is a significant risk factor for placental syndromes.
  • Placental syndromes are associated with an increased risk of future hypertension and CVD in women.
  • The causal relationship between placental dysfunction and maternal hypertension remains unclear.

Conclusions:

  • There is a critical need for longitudinal studies assessing cardiac and vascular structure/function before, during, and after pregnancy.
  • Such studies are essential to determine whether placental issues cause or are consequences of elevated blood pressure in women.
  • Findings will inform precision medicine approaches for preventing and treating placental syndromes and chronic hypertension in women.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.1K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.5K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
36
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
31